buprenorphine
Studies associated with:
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0079 | Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) | John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D. | |
| CTN | NIDA-CTN-0095A2 | Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians | Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D. | |
| CTN | NIDA-CTN-0051A2 | Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051 | John Rotrosen, M.D. | |
| CTN | NIDA-CTN-0075 | Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder | Li-Tzy Wu, Psy.D., Paolo Mannelli, MD | |
| CTN | NIDA-CTN-0051 | Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment | John Rotrosen, M.D. | |
| CTN | NIDA-CTN-0048 | Cocaine Use Reduction with Buprenorphine (CURB) | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0030A3 | Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) | Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D. | |
| CTN | NIDA-CTN-0030 | A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence | Walter Ling, M.D., Roger Weiss, M.D. | |
| CTN | NIDA-CTN-0027 | Starting Treatment with Agonist Replacement Therapies (START) | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0010 | Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults | George Woody, M.D. | |
| CTN | NIDA-CTN-0003 | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0002 | Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0001 | Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification | Walter Ling, M.D. | |
| DTMC | NIDA-CSP-1018 | A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Walter Ling, M.D., Paul J. Fudala, Ph.D., Paul Casadonte, M.D. | |
| DTMC | NIDA-CSP-1008B | A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Peter Bridge, M.D. | |
| DTMC | NIDA-CSP-1008A | A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence | Peter Bridge, M.D., Paul J. Fudala, Ph.D. | |
| DTMC | NIDA-CSP-999 | A Multicenter Clinical Trial of Buprenorphine in Treatment of Opiate Dependence | Walter Ling, M.D., Donald R. Wesson, M.D., C. James Klett, Ph.D. |